Title : Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer.

Pub. Date : 2019 Jun 1

PMID : 30624616






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer. Doxorubicin erb-b2 receptor tyrosine kinase 2 Homo sapiens